The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction

Excessive inflammation after myocardial infarction (MI) can promote infarct expansion and adverse left ventricular (LV) remodeling. L-4F, a mimetic peptide of apolipoprotein A-I (apoA-I), exhibits anti-inflammatory and anti-atherogenic properties; however, whether L-4F imparts beneficial effects aft...

Full description

Bibliographic Details
Main Authors: Tariq Hamid, Mohamed Ameen Ismahil, Shyam S. Bansal, Bindiya Patel, Mehak Goel, C. Roger White, G. M. Anantharamaiah, Sumanth D. Prabhu
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/10/3519
id doaj-11071899cf14467f965cd7e7ca02b5df
record_format Article
spelling doaj-11071899cf14467f965cd7e7ca02b5df2020-11-25T03:12:45ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-05-01213519351910.3390/ijms21103519The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial InfarctionTariq Hamid0Mohamed Ameen Ismahil1Shyam S. Bansal2Bindiya Patel3Mehak Goel4C. Roger White5G. M. Anantharamaiah6Sumanth D. Prabhu7Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Gerontology, Geriatrics, and Palliative Care, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USAExcessive inflammation after myocardial infarction (MI) can promote infarct expansion and adverse left ventricular (LV) remodeling. L-4F, a mimetic peptide of apolipoprotein A-I (apoA-I), exhibits anti-inflammatory and anti-atherogenic properties; however, whether L-4F imparts beneficial effects after myocardial infarction (MI) is unknown. Here we demonstrate that L-4F suppresses the expansion of blood, splenic, and myocardial pro-inflammatory monocytes and macrophages in a mouse model of reperfused MI. Changes in immune cell profiles were accompanied by alleviation of post-MI LV remodeling and dysfunction. In vitro, L-4F also inhibited pro-inflammatory and glycolytic gene expression in macrophages. In summary, L-4F treatment prevents prolonged and excessive inflammation after MI, in part through modulation of pro-inflammatory monocytes and macrophages, and improves post-MI LV remodeling. These data suggest that L-4F could be a used as a therapeutic adjunct in humans with MI to limit inflammation and alleviate the progression to heart failure.https://www.mdpi.com/1422-0067/21/10/3519inflammationheart failurecardiac remodelingmacrophage polarity
collection DOAJ
language English
format Article
sources DOAJ
author Tariq Hamid
Mohamed Ameen Ismahil
Shyam S. Bansal
Bindiya Patel
Mehak Goel
C. Roger White
G. M. Anantharamaiah
Sumanth D. Prabhu
spellingShingle Tariq Hamid
Mohamed Ameen Ismahil
Shyam S. Bansal
Bindiya Patel
Mehak Goel
C. Roger White
G. M. Anantharamaiah
Sumanth D. Prabhu
The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction
International Journal of Molecular Sciences
inflammation
heart failure
cardiac remodeling
macrophage polarity
author_facet Tariq Hamid
Mohamed Ameen Ismahil
Shyam S. Bansal
Bindiya Patel
Mehak Goel
C. Roger White
G. M. Anantharamaiah
Sumanth D. Prabhu
author_sort Tariq Hamid
title The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction
title_short The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction
title_full The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction
title_fullStr The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction
title_full_unstemmed The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction
title_sort apolipoprotein a-i mimetic l-4f attenuates monocyte activation and adverse cardiac remodeling after myocardial infarction
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2020-05-01
description Excessive inflammation after myocardial infarction (MI) can promote infarct expansion and adverse left ventricular (LV) remodeling. L-4F, a mimetic peptide of apolipoprotein A-I (apoA-I), exhibits anti-inflammatory and anti-atherogenic properties; however, whether L-4F imparts beneficial effects after myocardial infarction (MI) is unknown. Here we demonstrate that L-4F suppresses the expansion of blood, splenic, and myocardial pro-inflammatory monocytes and macrophages in a mouse model of reperfused MI. Changes in immune cell profiles were accompanied by alleviation of post-MI LV remodeling and dysfunction. In vitro, L-4F also inhibited pro-inflammatory and glycolytic gene expression in macrophages. In summary, L-4F treatment prevents prolonged and excessive inflammation after MI, in part through modulation of pro-inflammatory monocytes and macrophages, and improves post-MI LV remodeling. These data suggest that L-4F could be a used as a therapeutic adjunct in humans with MI to limit inflammation and alleviate the progression to heart failure.
topic inflammation
heart failure
cardiac remodeling
macrophage polarity
url https://www.mdpi.com/1422-0067/21/10/3519
work_keys_str_mv AT tariqhamid theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT mohamedameenismahil theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT shyamsbansal theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT bindiyapatel theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT mehakgoel theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT crogerwhite theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT gmanantharamaiah theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT sumanthdprabhu theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT tariqhamid apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT mohamedameenismahil apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT shyamsbansal apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT bindiyapatel apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT mehakgoel apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT crogerwhite apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT gmanantharamaiah apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
AT sumanthdprabhu apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction
_version_ 1724648688471506944